Cilengitide in newly diagnosed glioblastoma with MGMT promoter methylation: Protocol of a multicenter, randomized, open-label, controlled phase III trial (CENTRIC).
暂无分享,去创建一个
R. Stupp | M. Weller | M. Hegi | D. Reardon | H. Wheeler | S. Erridge | M. Bent | J. Perry | Yong-Kil Hong | M. Picard